Pharmaceutical Marketing Trends after COVID-19 Pandemic: A Comprehensive Review

References

[1] Anthuvan, T., Maheshwari, K., & Dantu, R. (2024). Trends in pharmaceutical marketing and branding research: A bibliometric analysis (2009–2023). IIM Ranchi Journal of Management Studies, 4(1), 55–71. https://doi.org/10.1108/IRJMS-03-2024-0030

[2] Mohan, M., Rajendiran, K., Rajaram, Y., Balaji, S., & Cassinadane, A. (2024). Current trends in pharmaceutical industry: Post-COVID-19 pandemic effects. Bioinformation, 20(12), 1784–1788. https://doi.org/10.6026/9732063002001784

[3] Singh, N. (2023). Pharmaceutical marketing: Post-COVID growth in the industry. International Journal of Scientific Development and Research, 8(3), 817–820.

[4] Srivastava, R., & Dabhade, N. (2023). Impact of pharmaceutical marketing on doctors’ prescribing behaviour in the post-COVID era: A critical review. Journal of Propulsion Technology, 44(5).

[5] Najam, U., Ali, R., & Burki, U. (2023). Advertising during the COVID-19 pandemic: Trends and theoretical developments. Administrative Sciences, 13(7), 170. https://doi.org/10.3390/admsci13070170

[6] Kumar, V., & Pansari, A. (2023). Transformative marketing in the new normal: Opportunities and challenges. Journal of Business Research, 160, 113638. https://doi.org/10.1016/j.jbusres.2022.113638

[7] Narayanan, S., Desiraju, R., & Chintagunta, P. (2024). Branded response to generic entry: Pharmaceutical promotion strategies. International Journal of Research in Marketing, 41(3), 567–588. https://doi.org/10.1016/j.ijresmar.2023.12.004

[8] Lexchin, J. (2023). Pharmaceutical promotion in the digital age: Implications after COVID-19. BMJ Global Health.

[9] IQVIA Institute. (2024). Digital transformation in healthcare and pharma marketing: Post-pandemic insights. IQVIA Report.

[10] Deloitte. (2023). Global life sciences outlook: Evolution of pharmaceutical marketing post COVID-19. Deloitte Insights.

[11] McKinsey & Company. (2024). The future of pharma commercial model: Omnichannel engagement after COVID-19.

[12] PwC Health Research Institute. (2023). Pharma 2025: Marketing transformation in a post-pandemic world.

[13] Accenture. (2024). Reinventing pharmaceutical marketing through AI and digital engagement.

[14] Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2023). The high cost of pharmaceutical marketing and its impact on prescribing. JAMA.

[15] Ventola, C. L. (2023). Social media and digital marketing in pharmaceuticals: Emerging post-pandemic trends. P&T Journal.

@article{1717836,
      author = {Nikhil Kumar, Shubham Kumar, Ritik Kumar, Utkarsh Shukla, Sangeeta Singh},
      title = {Pharmaceutical Marketing Trends after COVID-19 Pandemic: A Comprehensive Review},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {11},
      pages = {1373-1377},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1717836.pdf},
      abstract = {The COVID-19 pandemic significantly transformed the pharmaceutical industry, particularly in marketing strategies. Traditional face-to-face interactions were replaced by digital engagement, reshaping how pharmaceutical companies interact with healthcare professionals (HCPs) and patients. This review explores post-pandemic pharmaceutical marketing trends, including digital transformation, omnichannel marketing, telemedicine integration, data-driven personalization, patient-centric approaches, and regulatory changes. The study synthesizes recent literature to provide insights into evolving marketing strategies and future directions.},
      month = {May},
      doi = {https://doi.org/10.64388/IREV9I11-1717836}
  }